Latest Earnings Analysis

• AudioCodes (AUDC) Q1 2024: Legacy Gateway Revenue Down $12M, Accelerating Recurring Model Shift
  May 07, 2024 · AUDC
• AGEN Q1 2024: $100M Royalty Financing Secured, Accelerating Botensilimab Path to Approval
  May 07, 2024 · AGEN
• BTMD Q1 2024: 6.6% Procedure Growth Anchored in Existing Clinics as Internal Production Ramps
  May 07, 2024 · BTMD
• Bandwidth (BAND) Q1 2024: Messaging Grows 50%, Maestro Drives Enterprise Cloud Shift
  May 07, 2024 · BAND
• Arista Networks (ANET) Q1 2024: AI Ethernet Pipeline Expands as Guidance Lifts to 14%
  May 07, 2024 · ANET
• ATEC (ATEC) Q1 2024: Surgical Revenue Jumps 30% as Lateral Franchise Drives Market Share Gains
  May 07, 2024 · ATEC
• BellRing Brands (BRBR) Q2 2024: Premier Protein Drives 28% Sales Growth as Capacity Expansion Unlocks Demand
  May 07, 2024 · BRBR
• ASTH Q1 2024: Full Risk Contracts Surge to 60%, Accelerating Margin Expansion Path
  May 07, 2024 · ASTH
• BlackLine (BL) Q1 2024: Partner-Driven Deals Reach 75% as AI and Industry Focus Accelerate
  May 07, 2024 · BL
• AdaptHealth (AHCO) Q1 2024: EBITDA Margin Expands 200bps as Supply Chain and Diabetes Execution Drive Upside
  May 07, 2024 · AHCO
• Atkore (ATKR) Q2 2024: $80M Guidance Cut Tied to HDPE and Solar Delays Resets Near-Term Growth
  May 07, 2024 · ATKR
• Builders FirstSource (BLDR) Q1 2024: Value-Added Mix Hits 52%, Digital Orders Surpass $60M Post-Launch
  May 07, 2024 · BLDR
• Ameresco (AMRC) Q1 2024: Project Backlog Surges 36% as Margin Focus Sharpens
  May 07, 2024 · AMRC
• BioVentus (BVS) Q1 2024: EBITDA Margin Surges 300bps as HA and Surgical Outperform
  May 07, 2024 · BVS
• Alexanders (ALX) Q1 2024: $915M Revolver Extension Secures Liquidity Through 2029 Amid Vacancy Drag
  May 07, 2024 · ALX
• ADUS Q1 2024: Personal Care Drives 9.3% Organic Growth as Scale Strategy Counters 80-20 Rule
  May 07, 2024 · ADUS
• Astera Labs (ALAB) Q1 2024: AI Platform Revenue Soars 269% as PCIe and Ethernet Product Ramps Accelerate
  May 07, 2024 · ALAB
• Angel Oak Mortgage (AOMR) Q1 2024: Securitization Drives 26% Net Interest Income Surge, Balance Sheet Delevered to 0.5x
  May 07, 2024 · AOMR
• APEI Q1 2024: EBITDA Margin Expands 600bps as Rasmussen Turnaround Gains Traction
  May 07, 2024 · APEI
• Boise Cascade (BCC) Q1 2024: EWP Volumes Surge 31% as Single-Family Tailwind Outpaces Market
  May 07, 2024 · BCC
• Apple Hospitality REIT (APLE) Q1 2024: $116.8M DC Acquisition Lifts Portfolio Yield, Signals Urban Expansion
  May 07, 2024 · APLE
• Alico (ALCO) Q2 2024: $28.5M Inventory Write-Down Sharpens Focus on Citrus Recovery and Land Monetization
  May 07, 2024 · ALCO
• Aramark (ARMK) Q2 2024: Organic Revenue Climbs 9% as Supply Chain Scale Drives Margin Expansion
  May 07, 2024 · ARMK
• ADTRAN (ADTN) Q1 2024: Access & Aggregation Surges 27%, Inventory Headwinds Ease
  May 07, 2024 · ADTN
• BCSF Q1 2024: Originations Surge 31% as Core Middle Market Focus Drives Portfolio Resilience
  May 07, 2024 · BCSF
• AOSL Q3 2024: Computing Segment Grows 80% as Inventory Correction Nears End
  May 07, 2024 · AOSL
• Aclaris Therapeutics (ACRS) Q1 2024: ATI-2138 Shows 44x ITK Potency Over Pfizer’s Ritlicitinib, Sets Up Atopic Dermatitis Pivot
  May 07, 2024 · ACRS
• BWMN Q1 2024: Backlog Surges 31% as CertX Deal Expands Margin and Public Sector Reach
  May 07, 2024 · BWMN
• AESI Q1 2024: $20–$40M EBITDA Impact Flags Resilience as Dune Express Nears Completion
  May 06, 2024 · AESI
• ADEA (ADEA) Q1 2024: 10 New License Agreements Anchor OTT and Semiconductor Expansion
  May 06, 2024 · ADEA
• ADC Therapeutics (ADCT) Q1 2024: $105M Financing Extends Runway as Zynlonta Pipeline Expands
  May 06, 2024 · ADCT
• Artivion (AORT) Q1 2024: EBITDA Margin Expands 480bps as Proprietary Portfolio Drives Global Growth
  May 06, 2024 · AORT
• Axon (AXON) Q1 2024: Cloud & Services Revenue Up 51%, AI and Drone Platform Set Strategic Expansion
  May 06, 2024 · AXON
• AMG (AMG) Q1 2024: Alternatives Now 50% of Earnings as Private Markets AUM Hits $120B
  May 06, 2024 · AMG
• Alpha Metallurgical Resources (AMR) Q1 2024: Met Coal Realizations Drop 14% as Market Weakness Drives Cost Discipline
  May 06, 2024 · AMR
• AGM Q1 2024: Securitization Demand Triples as Rural Lending Pipeline Builds
  May 06, 2024 · AGM
• Alto Ingredients (ALTO) Q1 2024: Specialty Alcohol Sales Up 24%, CCS Execution Takes Center Stage
  May 06, 2024 · ALTO
• BioCryst (BCRX) Q1 2024: Orladeyo Revenue Jumps 30% as Pipeline Readies for Clinical Expansion
  May 06, 2024 · BCRX
• BioNTech (BNTX) Q1 2024: R&D Spend Jumps 52% as Oncology Pipeline Accelerates Toward 10 Pivotal Trials
  May 06, 2024 · BNTX
• BWXT (BWXT) Q1 2024: Cambridge Expansion Drives 25% Capacity Boost as Nuclear Demand Accelerates
  May 06, 2024 · BWXT
• Axsome Therapeutics (AXSM) Q1 2024: Avelity Prescriptions Jump 206% as Coverage Expands, Pipeline Milestones Stack Up
  May 06, 2024 · AXSM
• AES (AES) Q1 2024: Data Center Contracts Push Backlog to 12.7 GW, Locking in Renewables Demand Surge
  May 03, 2024 · AES
• AdvanSix (ASIX) Q1 2024: $27M Disruption Masks Fertilizer and Acetone Margin Tailwinds
  May 03, 2024 · ASIX
• Adient (ADNT) Q2 2024: Asia Margins Lead as $125M Europe Restructuring Targets Long-Term Profitability
  May 03, 2024 · ADNT
• Ameren (AEE) Q1 2024: $55B Investment Pipeline Anchors Grid and Renewables Growth Amid Regulatory Flux
  May 03, 2024 · AEE
• Alamo Group (ALG) Q1 2024: Industrial Equipment Sales Jump 30% as Vegetation Bookings Sink 41%
  May 03, 2024 · ALG
• ACCO (ACCO) Q1 2024: Gross Margin Expands 120bps as Cost Controls Offset 11% Sales Decline
  May 03, 2024 · ACCO
• Atmus (ATMU) Q1 2024: Aftermarket Share Gains Offset Softer Freight, Guidance Holds at $1.61B–$1.675B
  May 03, 2024 · ATMU
• Balchem (BCPC) Q1 2024: Human Nutrition and Health Surges 15% as Animal Segment Faces Import Pressure
  May 03, 2024 · BCPC
• AMH Q1 2024: Dispositions Unlock $145M as Development Yields Hold Near 6%
  May 03, 2024 · AMH